MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-KR-02-0005067
Lyrus Life Sciences Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹60.95 Cr
▼ 22% YoY
Net loss · FY 2025
₹11.73 Cr
Net margin -19.2%
EBITDA · FY 2025
₹5.21 Cr
EBITDA margin 8.6%
Authorised capital
₹96.25 Cr
Registered with MCA
Paid-up capital
₹96.23 Cr
Issued & subscribed
Open charges
₹30 Cr
Satisfied ₹56.63 Cr
Company age
11 yrs
Est. 2015
Employees · EPFO
104
Provident fund records
About Lyrus Life Sciences Private Limited
Data last updated:
Lyrus Life Sciences Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 16 June 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24230KA2015PTC080902. Its GSTIN is 29AACCL8757E1Z5 (Karnataka).
The company has an authorised share capital of ₹96.25 Cr and a paid-up capital of ₹96.23 Cr. It is led by directors Hemanth Kumar Bothra (Managing Director) and Leela Kanwar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.22 7th Cross Jaibharath Nagar, Bangalore, Karnataka, India – 560033.
As per the financials filed for FY 2025, the company reported a revenue of ₹60.95 Cr, a decline of 22% compared to the previous year. For the same year it recorded a net loss of ₹11.73 Cr (net margin -19.2%) and EBITDA of ₹5.21 Cr (EBITDA margin 8.6%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 2% over five years.
The company has about 104 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Lyrus Life Sciences. As per MCA filings, the company has open charges of ₹30 Cr and satisfied charges of ₹56.63 Cr on record. Court records list 7 cases involving the company, including 7 filed by the company; 1 case is pending. The company has 13 deals on record (6 convertible or debt financings, 4 rights issues, 2 acquisitions), with disclosed funding of ₹68.33 Cr; the latest was in December 2023. Its 3 peer companies in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development) are compared by revenue, 2 larger and 1 smaller; the largest is RCC Laboratories India Private Limited with revenue of ₹68.9 Cr. The company has 12 MSME Form 1 returns on record between 2019 and 2024, listing 671 overdue payments to 84 micro and small suppliers.
Lyrus Life Sciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-02-0005067). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lyruslife.com.
Company details
CIN U24230KA2015PTC080902
Registration Number 080902
Incorporation Date 16 June 2015
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-KR-02-0005067
Recognitions & Rankings of Lyrus Life Sciences
Contact details
Lyrus Life Sciences Private Limited's registered office is in Bangalore, Karnataka. Its website is lyruslife.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo.22 7th Cross Jaibharath Nagar, Bangalore, Karnataka, India – 560033
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Lyrus Life Sciences Private Limited, buy the company report.
Comprehensive company report
Lyrus Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Lyrus Life Sciences operates one associated brand: Lyrus Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Research-driven firm specializing in pharmaceutical formulation development and manufacturing services. | lyruslife.com |
Business activity
The main business activities of Lyrus Life Sciences are professional, scientific and technical and trade. In detail, this covers scientific research and development and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Lyrus Life Sciences Private Limited, buy the company report.
Financials of Lyrus Life Sciences Private Limited
FY 2025 filings availableLyrus Life Sciences Private Limited reported revenue of ₹60.95 Cr (down 22% YoY) for FY 2025.
Revenue · FY 2025
₹60.95 Cr ▼ 22%
Net loss · FY 2025
₹11.73 Cr margin -19.2%
EBITDA · FY 2025
₹5.21 Cr margin 8.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 22%
3 years · compounded
▼ 13%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▼ 36%
3 years · compounded
▼ 25%
5 years · compounded
▲ 21%
Revenue fell 22% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.21 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹11.73 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.6% | ||||
| Net Profit Margin | -19.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lyrus Life Sciences Private Limited, buy the company report.
Board of directors of Lyrus Life Sciences Private Limited
Lyrus Life Sciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hemanth Kumar Bothra | Managing Director | 16 Jun 2015 | 11 Years 4 Months | Current |
| Leela Kanwar | Director | 16 Jun 2015 | 11 Years 4 Months | Current |
Peer comparison
Lyrus Life Sciences Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| RCC Laboratories India Private Limited | ₹68.9 Cr (FY 2025) | 31.0% | Telangana, India | |||
| Fortrea Clinical Development Private Limited | ₹64.26 Cr (FY 2025) | -8.0% | Bangalore, Karnataka, India | |||
| Lyrus Life Sciences Private Limitedthis company | ₹60.95 Cr (FY 2025) | -₹11.73 Cr | -19.2% | -22.0% | 104 | Bangalore, Karnataka, India |
| MMSH Clinical Research Private Limited | ₹60.32 Cr (FY 2025) | 3.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Lyrus Life Sciences Private Limited, buy the company report.
Auditor
Lyrus Life Sciences Private Limited is audited by K.S.AIYAR & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K.S.AIYAR & CO | FY 2023 | 100186W |
Shareholding
The shareholding of Lyrus Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lyrus Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹30 Cr
Satisfied charges
₹56.63 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Feb 2025 | 101044298 | Others | ₹30 Cr | Open | |
| 28 Feb 2024 | 100874309 | State Bank of India | ₹18.5 Cr | Satisfied | |
| 04 Sep 2018 | 100203676 | Canara Bank | ₹38.13 Cr | Satisfied |
To see the full charge records of Lyrus Life Sciences Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Lyrus Life Sciences Private Limited has 13 deals on record (6 convertible or debt financings, 4 rights issues, 2 acquisitions), with disclosed funding of ₹68.33 Cr; the latest was in December 2023.
Total deals
13
Convertible or debt financings
6
Rights issues
4
Acquisitions
2
Secondary share transfer
1
Disclosed funding
₹68.33 Cr
Deals on record (5 of 13)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2018 | Rights issue | ₹10.35 Cr | Investors: Nokha Trading LLP |
| Jun 2017 | Rights issue | ₹22.01 Cr | Investors: Nokha Trading LLP |
| Dec 2016 | Rights issue | ₹78.4 Lakh | Investors: an individual |
| Jul 2016 | Acquisition | ₹17.97 Cr | Buyer: Nokha Trading LLP |
| Feb 2016 | Acquisition | ₹12.91 Cr | Buyer: Nokha Trading LLP |
To see the full deal history of Lyrus Life Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Lyrus Life Sciences Private Limited has 7 court cases on record: 7 filed by Lyrus Life Sciences. 1 case is pending and 6 are disposed.
Total cases
7
Filed by the company
7
Pending
1
Disposed
6
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 0 | 0 |
| District courts | 3 | 0 | 1 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Court case (Reg Dkst) | Filed by the company against Celogen Pharma Pvt Ltd Through Mr T P Mathews | Pending |
| High Court of Karnataka | Interim or miscellaneous application | Filed by the company against M/S Acme Generics LLP | Disposed |
| High Court of Karnataka | Interim or miscellaneous application | Filed by the company against M/S Celogen Pharma Pvt. Ltd., | Disposed |
| High Court | Interim or miscellaneous application | Filed by the company against an individual | Disposed |
| District court, BENGALURU, Karnataka | Court case (Com.O.S.) | Filed by the company against individuals | Disposed |
To see the full case history of Lyrus Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Lyrus Life Sciences Private Limited was last rated by Care on 18 Jul 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 18 Jul 2022 |
To see the full credit ratings and regulatory alerts of Lyrus Life Sciences Private Limited, buy the company report.
MSME payment delays
Lyrus Life Sciences Private Limited has 12 MSME Form 1 returns on record between 2019 and 2024, listing 671 overdue payments to 84 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 84)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Amartara Private Limited | |||
| LCGC Bioanalytic Solutions LLP | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Lyrus Life Sciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Lyrus Life Sciences Private Limited has a workforce of 104 employees on its EPFO records as of Apr 03, 2024, across 1 active EPFO establishment.
Employee count
104
Active EPFO establishments
1
Employee growth
-20.61%
GST
Lyrus Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AACCL8757E1Z5 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lyrus Life Sciences Private Limited, buy the company report.
Recent activity
Lyrus Life Sciences Private Limited has 4 board changes on record since 2015: 3 appointments and 1 cessation. The latest: Chillale Govindaraj ceased to be Director on 16 Aug 2018.
AGM
Lyrus Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Lyrus Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Charges
A charge registered on 28 Feb 2024 via Charge ID 100874309 with State Bank Of India was fully satisfied on 10 Feb 2025.
Charges
A charge with Others amounted to Rs. 30.00 Cr with Charge ID 101044298 was registered on 07 Feb 2025.
Charges
A charge with State Bank Of India amounted to Rs. 18.50 Cr with Charge ID 100874309 was registered on 28 Feb 2024.
Charges
A charge registered on 04 Sep 2018 via Charge ID 100203676 with Canara Bank was fully satisfied on 26 Feb 2024.
Charges
A charge with Canara Bank of Rs. 38.13 Cr registered on 04 Sep 2018 with Charge ID 100203676 was modified on 30 May 2023.
Charges
A charge with Canara Bank amounted to Rs. 38.13 Cr with Charge ID 100203676 was registered on 04 Sep 2018.
Ceased
Chillale Govindaraj ceased to be Director.
Appointed
Dasari Ramesh was appointed as Company Secretary.
Appointed
Hemanth Kumar Bothra was appointed as Managing Director.
Appointed
Leela Kanwar was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Lyrus Life Sciences is an active private limited company based in Bangalore, Karnataka, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 16 June 2015 (11+ years old) and is registered under CIN U24230KA2015PTC080902.
Lyrus Life Sciences has 2 current directors:
- Hemanth Kumar Bothra - Managing Director
- Leela Kanwar - Director
The latest financial statements of Lyrus Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Lyrus Life Sciences is 29AACCL8757E1Z5, registered in Karnataka.
The CIN (Corporate Identification Number) of Lyrus Life Sciences is U24230KA2015PTC080902. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lyrus Life Sciences has 7 court cases on record: 7 filed by the company. 1 is pending. Most are in the high courts.
Lyrus Life Sciences was incorporated on 16 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Bangalore.
Lyrus Life Sciences has 13 deals on record (6 convertible or debt financings, 4 rights issues, 2 acquisitions), with disclosed funding of ₹68.33 Cr; the latest was in December 2023.
The peers of Lyrus Life Sciences by revenue are RCC Laboratories India Private Limited, Fortrea Clinical Development Private Limited, MMSH Clinical Research Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).
Chillale Govindaraj ceased to be Director on 16 Aug 2018. Dasari Ramesh was appointed as Company Secretary on 20 Jun 2017. Hemanth Kumar Bothra was appointed as Managing Director on 16 Jun 2015. Lyrus Life Sciences has 4 board changes on record in total.
Yes, Lyrus Life Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-KR-02-0005067).
Lyrus Life Sciences has 12 MSME Form 1 returns on record between 2019 and 2024, listing 671 overdue payments to 84 micro and small suppliers. The latest return was filed on 23 Apr 2024.